CYN-154806
CYN-154806 is a synthetic peptide that acts as a selective antagonist of the melanocortin receptor subtype 4 (MC4R). It is primarily used in research settings to study the physiological and pathological roles of the MC4R, which is involved in the regulation of energy homeostasis, feeding behavior, and body weight.
Structure and Mechanism of Action[edit | edit source]
CYN-154806 is a cyclic peptide with a specific sequence that allows it to bind selectively to the MC4R. The MC4R is a G protein-coupled receptor (GPCR) that is activated by endogenous melanocortin peptides such as α-MSH (alpha-melanocyte-stimulating hormone). By acting as an antagonist, CYN-154806 inhibits the action of these peptides, thereby blocking the receptor's activity.
Pharmacological Effects[edit | edit source]
In preclinical studies, CYN-154806 has been shown to:
- Inhibit the anorexigenic effects of MC4R agonists, leading to increased food intake in animal models.
- Modulate energy expenditure and body weight, providing insights into the role of MC4R in obesity and metabolic disorders.
- Affect sexual function and behavior, as MC4R is also expressed in the central nervous system regions involved in these processes.
Research Applications[edit | edit source]
CYN-154806 is used extensively in research to:
- Investigate the role of MC4R in obesity and metabolic syndrome.
- Study the neural circuits involved in the regulation of appetite and energy balance.
- Explore potential therapeutic targets for the treatment of anorexia nervosa and other eating disorders.
Potential Therapeutic Implications[edit | edit source]
While CYN-154806 itself is not used clinically, understanding its effects on MC4R can aid in the development of new drugs for conditions such as obesity, cachexia, and sexual dysfunction. By elucidating the pathways and mechanisms involved, researchers can design more effective therapies with fewer side effects.
Safety and Toxicology[edit | edit source]
As with many investigational compounds, the safety profile of CYN-154806 is primarily characterized in animal models. It is important to note that while it provides valuable insights into MC4R function, its use in humans is limited to research settings.
Also see[edit | edit source]
Template:Receptor pharmacology
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD